Opinion
No. 57143.
05-16-2012
SICOR, INC.; Teva Parenteral Medicines, Inc. f/k/a Sicor Pharmaceuticals, Inc.; Baxter Healthcare Corporation; and Mckesson Medical–Surgical, Inc., Appellants, v. Maria V. PAGAN, Individually; And William I. Bilger, Jr. and Marilyn Elaine Bilger, Husband and Wife, Respondents.
Alan M. Dershowitz Goodwin Procter, LLP/Boston Kirkland & Ellis LLP/New York Kirkland & Ellis LLP/Washington DC Lewis & Roca, LLP/Las Vegas Olson, Cannon, Gormley & Desruisseaux Cottle Law Firm Eglet Wall Kemp, Jones & Coulthard, LLP
Alan M. Dershowitz
Goodwin Procter, LLP/Boston
Kirkland & Ellis LLP/New York
Kirkland & Ellis LLP/Washington DC
Lewis & Roca, LLP/Las Vegas
Olson, Cannon, Gormley & Desruisseaux
Cottle Law Firm
Eglet Wall
Kemp, Jones & Coulthard, LLP
ORDER DISMISSING APPEAL
This is an appeal from a district court order denying without prejudice appellants' motion to change the place of trial. Eighth Judicial District Court, Clark County; Timothy C. Williams, Judge.
This court previously issued a show cause order directing appellants to show cause as to whether the venue change order, challenged in this appeal, constitutes a final ruling on the motion to change the place of trial so that the order is appealable under NRAP 3A(b)(6). See Sicor, Inc. v. Sacks, 127 Nev. ––––, 266 P.3d 618 (2011) (concluding that an order denying a motion without prejudice to change the place of trial and deferring a final ruling on the motion until after jury selection had been completed did not constitute a final order disposing of the motion to change venue, and thus, was not appealable under NRAP 3A(b)(6) ). Appellants have submitted a response to this court's order in which they concede that the order challenged in this appeal is not appealable. We therefore conclude that, as the challenged order is not substantively appealable under NRAP 3(A)(b)(6), this court lacks jurisdiction to consider this appeals and, as a result, we,
ORDER this appeal DISMISSED.